Impact of probiotic-mediated adenosine metabolism in regulating immune dysfunction.
益生菌介导的腺苷代谢对调节免疫功能障碍的影响。
基本信息
- 批准号:10201464
- 负责人:
- 金额:$ 7.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-25 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:5&apos-NucleotidaseAdenosineAffectAgonistAnaerobic BacteriaAnimalsAnti-Inflammatory AgentsAutoimmuneAutoimmune DiseasesAutoimmunityBiologyBloodBreathingBreedingCTLA4 geneCellsClinicalCommon Variable ImmunodeficiencyDiseaseEczemaEngineered ProbioticsEnzymesEragrostisEvolutionFOXP3 geneFemaleGene DeletionGenerationsGenesGeneticGoalsGut MucosaHealthHematopoietic Stem Cell TransplantationHomeostasisHumanIL2RA geneImmuneImmune System DiseasesImmune ToleranceImmune systemImmunologic Deficiency SyndromesImmunologicsInflammationInflammatoryInosineInsulin-Dependent Diabetes MellitusIntestinesKnock-outLaboratoriesLactobacillus reuteriLeadLeukocytesLifeLife ExpectancyLinkLongevityLung InflammationMediatingMetabolismMultiple SclerosisMusMutateMutationNucleoside TransporterOralOral AdministrationOutcomePathway interactionsPatientsPhenotypePhysiological ProcessesPreventiveProbioticsProcessProductionPurinergic P1 ReceptorsRegulatory T-LymphocyteResearchRoleSTAT1 geneSeveritiesSeverity of illnessSignal TransductionSingle-Gene DefectSyndromeT-Cell DevelopmentT-LymphocyteTherapeutic EffectWiskott-Aldrich Syndromeabsorptionadenosine deaminaseclinical phenotypecongenital immunodeficiencydysbiosiseffector T cellexperimental studyextracellularfeedinggut microbesgut microbiotaimmunoregulationimprovedinfancyinnovationinsightmalemicrobialmouse modelnovelnovel strategiesreceptorscreeningskin lesionsystemic inflammatory responsetranscriptomics
项目摘要
PROJECT SUMMARY/ABSTRACT
Oral feeding of a probiotic (Lactobacillus reuteri DSM 17938) to mice with 2 experimental autoimmune diseases
can reprogram the gut microbes and markedly reduce disease severity. One mouse model is essentially the same
as a condition in humans called IPEX syndrome (immunodeficiency and polyendocrinopathy, with x-linked
inheritance). LR 17938 reduced the severity of the mouse’s skin lesions, improved breathing and lung
inflammation, and prolonged the mouse’s life span from less than 1 month to > 4 months. Our studies identified
a novel mechanism in which an adenosine, a rapid-acting anti-inflammatory molecule released from ATP, by
interacting with its receptor on white blood cells (T cells) was responsible for the probiotic LR 17938 to improve
the animal’s health. We also recently found that LR 17938 improves health in a mouse model of multiple
sclerosis.
Adenosine generated from ATP is broken down by 2 intestinal enzymes, CD39 and CD73, called
ectonucleotidases. CD 39 and CD 73 are present on white blood cells and intestinal cells, but certain probiotics
can also convert ATP to adenosine. Adenosine is transported into gut mucosa by nucleoside transporters (NTs).
After absorption, adenosine and its active product inosine interact with a receptor (A2A) on T cells to inhibit
inflammation in the body.
A major gap in probiotic biology is our lack of understanding of how LR 17938 affects the adenosine pathway
during Treg deficiency. We found that probiotic LR 17938 contains 5NTE (CD73) gene and that LR 17938 would
be able to generate adenosine from AMP when anaerobically cultured the laboratory. However, a LR 17938 strain
with a 5NTE mutation (LR 179385NTE) could not generate adenosine from AMP.
Aim 1 is to assess the effects of LR 17938 to compare with LR 179385NTE on clinical outcome and the adenosine
pathway in SF mice. Aim 2 is to define the critical role of probiotic 5NTE (CD73) in autoimmune protection by
depleting host CD73 in SF mice. This study will lead to further investigate the mechanism of adenosine-
producing probiotic strain in interaction with host immune system, as well as in modulation of microbial
associated metabolites and transcriptomics in Treg deficiency. The long-term goal of these studies is to determine
how to choose the best probiotic to relieve primary autoimmune diseases in humans. These conditions include
IPEX syndrome due to Foxp3 gene mutation/deletion, and IPEX-like syndrome due to other single gene defects.
项目摘要/摘要
用2种实验性自身免疫性疾病的益生菌(Reuteri DSM 17938)的口服喂养(Reuteri DSM 17938)
可以重新编程肠道微生物并显着降低疾病的严重程度。一个鼠标模型本质上是相同的
作为人类中的一种称为IPEX综合征的疾病(免疫缺陷和多内分泌病,X连锁
遗产)。 LR 17938降低了鼠标皮肤病变的严重程度,呼吸改善和肺
炎症,并将鼠标的寿命从不到1个月延长到4个月。我们的研究确定了
一种新的机制,其中腺苷是一种从ATP释放的快速作用抗炎分子,
与其在白细胞上的受体相互作用(T细胞)是益生菌LR 17938的原因,以改善
动物的健康。我们最近还发现,LR 17938改善了多个鼠标模型的健康
硬化。
来自ATP产生的腺苷被2种肠酶CD39和CD73分解,称为
核苷酸酶。 CD 39和CD 73存在于白细胞和肠细胞上,但某些益生菌
还可以将ATP转换为腺苷。腺苷通过核苷转运蛋白(NTS)转运到肠粘膜中。
遭受痛苦后,腺苷及其活性产物的肌苷与T细胞上的接收器(A2A)相互作用以抑制
体内炎症。
益生菌生物学的主要差距是我们对LR 17938如何影响腺苷途径的了解不足
在Treg缺乏症中。我们发现益生菌LR 17938包含5NTE(CD73)基因,LR 17938将
当厌氧培养实验室时,能够从AMP中产生腺苷。但是,LR 17938菌株
具有5NTE突变(LR179385NTE)无法从AMP产生腺苷。
AIM 1是评估LR 17938与LR179385NTE对临床结果和腺苷的影响
SF小鼠的途径。 AIM 2是定义益生菌5NTE(CD73)在自身免疫保护中的关键作用
在SF小鼠中耗尽宿主CD73。这项研究将导致进一步研究腺苷的机制
与宿主免疫系统的相互作用以及微生物的调节中产生益生菌菌株
Treg缺乏症中的相关代谢物和转录组学。这些研究的长期目标是确定
如何选择最佳的益生菌来挽救人类原发性自身免疫性疾病。这些条件包括
由于FOXP3基因突变/缺失以及其他单一基因缺陷引起的IP3基因突变/缺失和IPEX样综合征。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg deficiency.
罗伊氏柠檬酸乳杆菌和鼠李糖乳杆菌 GG 对 Treg 缺陷小鼠的肠道微生物和代谢物产生不同的影响。
- DOI:10.1152/ajpgi.00072.2021
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Liu,Yuying;Hoang,ThomasK;Taylor,ChristopherM;Park,EvelynS;Freeborn,Jasmin;Luo,Meng;Roos,Stefan;Rhoads,JMarc
- 通讯作者:Rhoads,JMarc
Treg-associated monogenic autoimmune disorders and gut microbial dysbiosis.
- DOI:10.1038/s41390-021-01445-2
- 发表时间:2022-01
- 期刊:
- 影响因子:3.6
- 作者:Liu Y;Freeborn J;Armbrister SA;Tran DQ;Rhoads JM
- 通讯作者:Rhoads JM
Probiotic-derived ecto-5'-nucleotidase produces anti-inflammatory adenosine metabolites in Treg-deficient scurfy mice.
益生菌衍生的 ecto-5-核苷酸酶在 Treg 缺陷的头屑小鼠中产生抗炎腺苷代谢物。
- DOI:10.21203/rs.3.rs-2781715/v1
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Liu,Yuying;Armbrister,ShabbaA;Okeugo,Beanna;Mills,TingtingW;Daniel,RheaC;Oh,Jee-Hwan;Pijkeren,Jan-Peter;Park,EvelynS;Saleh,ZeinaM;Lahiri,Sharmistha;Roos,Stefan;Rhoads,JMarc
- 通讯作者:Rhoads,JMarc
The Association of Gut Microbiota and Treg Dysfunction in Autoimmune Diseases.
- DOI:10.1007/978-981-15-6407-9_10
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yuying Liu其他文献
Yuying Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yuying Liu', 18)}}的其他基金
Impact of probiotic-mediated adenosine metabolism in regulating immune dysfunction.
益生菌介导的腺苷代谢对调节免疫功能障碍的影响。
- 批准号:
10043458 - 财政年份:2020
- 资助金额:
$ 7.8万 - 项目类别:
Mechanisms of L. reuteri in regulating intestinal inflammation
罗伊氏乳杆菌调节肠道炎症的机制
- 批准号:
8913894 - 财政年份:2014
- 资助金额:
$ 7.8万 - 项目类别:
Mechanisms of L. reuteri in regulating intestinal inflammation
罗伊氏乳杆菌调节肠道炎症的机制
- 批准号:
8628976 - 财政年份:2014
- 资助金额:
$ 7.8万 - 项目类别:
相似国自然基金
烟酰胺单核苷酸腺苷转移酶3在酒精诱导的脂肪性肝病中的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
烟酰胺单核苷酸腺苷转移酶3在酒精诱导的脂肪性肝病中的作用及机制研究
- 批准号:82103839
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
腺苷酸琥珀酸合成酶样1(Adssl1)通过影响嘌呤核苷酸代谢调控褐色脂肪活性的作用研究
- 批准号:81974116
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
大肠埃希菌PNPase调控cAMP受体蛋白影响持留菌形成的机制研究
- 批准号:81902110
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
DNA修复酶家族成员TiPARP在非酒精性脂肪性肝病早期的作用及机制
- 批准号:81873568
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
A single-arm phase II study to evaluate the safety and efficacy of combination systematic chemotherapy and multiple rounds of endoscopic ultrasound-guided radiofrequency ablation in pancreatic cancer
评估联合系统化疗和多轮内镜超声引导射频消融治疗胰腺癌的安全性和有效性的单组 II 期研究
- 批准号:
10743356 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Targeting the CD73-adenosinergic pathway in head and neck cancer
靶向头颈癌中的 CD73 腺苷能通路
- 批准号:
10813613 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Cellular and Molecular Mechanisms Underlying Neuronal Type-specific Axon Regeneration
神经元类型特异性轴突再生的细胞和分子机制
- 批准号:
10587352 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
The Molecular function of ecto 5' nucleotidase in fusion-negative rhabdomyosarcoma
融合阴性横纹肌肉瘤中5端核苷酸酶的分子功能
- 批准号:
10462430 - 财政年份:2022
- 资助金额:
$ 7.8万 - 项目类别: